Evidence map›Paper›PMID 42162230›Full record

ArticleBone marrow transplantation2026

Conditioning dose adjustment in obese adult patients with severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: a propensity score-matched analysis.

Wenni He, Tingting Han, Yun He, Yuanyuan Zhang, Wei Han, Chenhua Yan, Xiaodong Mo, Yuhong Chen, Jingzhi Wang, Fan Lin and 8 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wenni He *Peking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Tingting Han *Peking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Yun HePeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Yuanyuan ZhangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Wei HanPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Chenhua YanPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Xiaodong MoPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.ORCID http://orcid.org/0000-0002-9881-7945
Yuhong ChenPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Jingzhi WangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Fan LinPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.ORCID http://orcid.org/0000-0002-0987-5917
Fengrong WangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Zhengli XuPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.ORCID http://orcid.org/0000-0002-5018-6507
Feifei TangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Jinsong JiaPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
Yu WangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.ORCID http://orcid.org/0000-0003-1253-7465
Xiaohui ZhangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.ORCID http://orcid.org/0000-0003-0245-6792
Xiaojun HuangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.ORCID http://orcid.org/0000-0002-2145-6643
Lanping XuPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China. lpxu_0415@sina.com.ORCID http://orcid.org/0000-0002-0267-1081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42162230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.